{
    "2020-02-19": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Why a Top World Stock Fund Likes Microsoft, Alibaba, and Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Microsoft",
                        "Alibaba",
                        "Johnson & Johnson",
                        "Top World Stock Fund"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Revolution Medicines Joins Amgen and Mirati in Quest for New Type of Cancer Drugs",
                "features": {
                    "keywords": [
                        "Revolution Medicines",
                        "Amgen",
                        "Mirati",
                        "Cancer Drugs"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Sanofi, J&J Join Forces With BARDA for Coronavirus Vaccine",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "J&J",
                        "BARDA",
                        "Coronavirus Vaccine"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "vaccines"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "We Wouldn't Be Too Quick To Buy Johnson & Johnson (NYSE:JNJ) Before It Goes Ex-Dividend",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Ex-Dividend"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}